title: [Selenium in oncology. Really "noli nocere"?].
authors.forename: R
authors.initials: R
authors.lastname: Mücke
authors.forename: J
authors.initials: J
authors.lastname: Büntzel
authors.forename: K G
authors.initials: KG
authors.lastname: Schönekaes
authors.forename: O
authors.initials: O
authors.lastname: Micke
mesh_terms: D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D012643:Selenium / Q000008:administration & dosage* / Q000009:adverse effects / Q000172:deficiency; D012651:Self Medication; D016896:Treatment Outcome
chemical_list: D012643:Selenium